Helen Sabzevari sold $2.0M of Precigen (PGEN)

Executed Jun 29, disclosed Jul 1, 2 days later.

Value, as filed

$2.0M

346,836 sh × $5.89

Executed

Jun 29

the trade date, as filed

Disclosed

Jul 1

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Helen Sabzevari President and CEO profile →

Helen Sabzevari (President and CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Precigen, Inc. (PGEN). The largest single filing was $2.0M of PGEN (346,836 sh × $5.89, as filed), executed Jun 29.

The name

PGEN

Precigen, Inc. PGEN · Healthcare · 21 filings in 24 months ticker →

Healthcare · Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to tar…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Helen Sabzevari in PGEN

PGENSALE Precigen, Inc. $520K
119,250 sh × $4.36
Exec May 28
Filed Jun 1 · 5:30 PM ET